620 related articles for article (PubMed ID: 15325872)
1. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
Meza MM; Kopplin MJ; Burgess JL; Gandolfi AJ
Environ Res; 2004 Oct; 96(2):119-26. PubMed ID: 15325872
[TBL] [Abstract][Full Text] [Related]
2. Environmental Arsenic Exposure and Urinary 8-OHdG in Arizona and Sonora.
Burgess JL; Meza MM; Josyula AB; Poplin GS; Kopplin MJ; McClellen HE; Stürup S; Lantz RC
Clin Toxicol (Phila); 2007; 45(5):490-8. PubMed ID: 17503254
[TBL] [Abstract][Full Text] [Related]
3. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
4. Distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water.
Christian WJ; Hopenhayn C; Centeno JA; Todorov T
Environ Res; 2006 Jan; 100(1):115-22. PubMed ID: 16337848
[TBL] [Abstract][Full Text] [Related]
5. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
[TBL] [Abstract][Full Text] [Related]
6. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population.
Caceres DD; Pino P; Montesinos N; Atalah E; Amigo H; Loomis D
Environ Res; 2005 Jun; 98(2):151-9. PubMed ID: 15820720
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
[TBL] [Abstract][Full Text] [Related]
8. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
9. Arsenic speciation in human hair: a new perspective for epidemiological assessment in chronic arsenicism.
Yáñez J; Fierro V; Mansilla H; Figueroa L; Cornejo L; Barnes RM
J Environ Monit; 2005 Dec; 7(12):1335-41. PubMed ID: 16307093
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.
Wu MM; Chiou HY; Hsueh YM; Hong CT; Su CL; Chang SF; Huang WL; Wang HT; Wang YH; Hsieh YC; Chen CJ
Toxicol Appl Pharmacol; 2006 Oct; 216(1):168-75. PubMed ID: 16806340
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
Adair BM; Moore T; Conklin SD; Creed JT; Wolf DC; Thomas DJ
Toxicol Appl Pharmacol; 2007 Jul; 222(2):235-42. PubMed ID: 17559899
[TBL] [Abstract][Full Text] [Related]
12. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico.
Coronado-González JA; Del Razo LM; García-Vargas G; Sanmiguel-Salazar F; Escobedo-de la Peña J
Environ Res; 2007 Jul; 104(3):383-9. PubMed ID: 17475235
[TBL] [Abstract][Full Text] [Related]
13. Effect of fasting on the pattern of urinary arsenic excretion.
Brima EI; Jenkins RO; Lythgoe PR; Gault AG; Polya DA; Haris PI
J Environ Monit; 2007 Jan; 9(1):98-103. PubMed ID: 17213949
[TBL] [Abstract][Full Text] [Related]
14. Intake of arsenic from water, food composites and excretion through urine, hair from a studied population in West Bengal, India.
Uchino T; Roychowdhury T; Ando M; Tokunaga H
Food Chem Toxicol; 2006 Apr; 44(4):455-61. PubMed ID: 16198037
[TBL] [Abstract][Full Text] [Related]
15. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
16. The effect of seafood consumption on the assessment of occupational exposure to arsenic by urinary arsenic speciation measurements.
Arbouine MW; Wilson HK
J Trace Elem Electrolytes Health Dis; 1992 Sep; 6(3):153-60. PubMed ID: 1483034
[TBL] [Abstract][Full Text] [Related]
17. Stability of arsenic species and insoluble arsenic in human urine.
Chen YC; Amarasiriwardena CJ; Hsueh YM; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1427-33. PubMed ID: 12433722
[TBL] [Abstract][Full Text] [Related]
18. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
[TBL] [Abstract][Full Text] [Related]
19. Arsenic exposure in Hungary, Romania and Slovakia.
Lindberg AL; Goessler W; Gurzau E; Koppova K; Rudnai P; Kumar R; Fletcher T; Leonardi G; Slotova K; Gheorghiu E; Vahter M
J Environ Monit; 2006 Jan; 8(1):203-8. PubMed ID: 16395480
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
Mann S; Droz PO; Vahter M
Toxicol Appl Pharmacol; 1996 Oct; 140(2):471-86. PubMed ID: 8887465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
